Navigation Links
Data4Cure's AI-Powered Biomedical Intelligence Cloud Features New Tools for Multidimensional Disease Mapping and Immune-Oncology Research
Date:1/24/2017

LA JOLLA, Calif., Jan. 24, 2017 /PRNewswire/ -- Data4Cure, Inc. today announced a series of updates and new case studies using its Biomedical Intelligence® Cloud - a semantic data-driven discovery platform designed to continuously grow knowledge from a multitude of genomic, molecular and clinical data that are accumulating rapidly in the field. These updates were presented at a session hosted by Data4Cure at the Precision Medicine World Conference (PMWC) in Mountain View, CA.

The company's Biomedical Intelligence® Cloud now includes new tools for immune-oncology research, improved applications for mapping the molecular basis of disease, and a new multidimensional version of the company's molecular stratification engine.

Data4Cure's platform is powered by CURIE™, a dynamic biomedical knowledge graph that is continuously updated with information dynamically extracted from a variety of data sources. Cross-referencing tens of thousands of datasets and bioinformatics analyses, literature, clinical trials and external databases, CURIE provides immediate data-driven answers to over 100 million biomedical questions.

"CURIE understands biology," said Janusz Dutkowski, Ph.D., CEO, Data4Cure, who chaired the PMWC session. "It combines advanced machine learning, systems biology and semantic search capabilities providing a new way to make discoveries. Our platform allows biological and clinical researchers to leverage diverse datasets to discover relationships between entities in a molecular system, and uncover how these entities and relations are affected by the disease and environment, and how they respond to drug interventions."

CURIE is used by multiple applications running on Data4Cure's Biomedical Intelligence Cloud. One of these presented in the update is the Disease Maps application which leverages a plethora of public and proprietary data to create up-do-date molecular maps for over 500 disease conditions including multiple cancer types, Alzheimer's disease, Rheumatoid arthritis, diabetes, and other metabolic, immunological and neurological disorders.

The company's platform also includes a redesigned network-based stratification engine which uses network maps along with genetic, epigenetic and transcriptional evidence to identify disease subtypes that are directly tied to the network and pathway-level activities and aberrations, and can be further associated with predicted sensitivity or resistance to selected drugs.

The newest additions to Biomedical Intelligence Cloud platform include tools for immune-oncology research that Data4Cure has been testing with selected pharmaceutical partner companies. "These tools include algorithms for inferring immune cell types infiltrating tumors as well as systems biology tools for interrogating immune pathway activities associated with specific diseases subtypes," said Roy Ronen, Ph.D., VP, Computational Biology at Data4Cure. The new tools are integrated with CURIE and other applications including the stratification and pathway analysis tools.

Launched in 2016, the Biomedical Intelligence Cloud has attracted customers and partners across some of the largest global pharmaceutical companies and leading research institutes. "We are very excited to work with some of the best research groups in the industry and academia," said Dutkowski. "By dramatically accelerating the access to data-driven knowledge and uncovering non-obvious connections hidden in millions of datasets, scientific papers and clinical trials we can really start to turn data into cures."

Learn more at www.data4cure.com

Media contact:

Maja Gawronska
maja@data4cure.com

This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/data4cures-ai-powered-biomedical-intelligence-cloud-features-new-tools-for-multidimensional-disease-mapping-and-immune-oncology-research-300395582.html


'/>"/>
SOURCE Data4Cure, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. MindMeld and Sense.ly Launch Solution to Enable a New Generation of AI-Powered Healthcare Applications
2. Boston Biomedical Announces Orphan Drug Designation for Napabucasin in Pancreatic Cancer
3. Terumo BCT Announces a $17.4 Million Funding Contract from the Biomedical Advanced Research and Development Authority (BARDA)
4. Boston Biomedicals Investigational Cancer Stem Cell Pathway Inhibitor, Napabucasin (BBI608), Featured at the ASCO 2016 Gastrointestinal Cancers Symposium
5. Spero Therapeutics Hires Former Biomedical Advanced Research and Development Authority (BARDA) Anti-Infectives Program Chief
6. California Institute for Biomedical Research (Calibr) enters worldwide strategic collaboration with Pfizer Inc.
7. Hologic Applauds Passage of Federal Measures that Preserve Access to Mammography for Breast Cancer Screening and Increase Incentives for Biomedical Research and Development
8. Avery Biomedical Devices nombra al doctor Anders Jonzon como consultor clínico
9. Avery Biomedical Devices ernennt Dr. Anders Jonzon zum Clinical Consultant
10. Avery Biomedical Devices appoints Dr. Anders Jonzon as Clinical Consultant
11. Uploads on Biomedical Authoring Platform F1000Workspace Exceed 1m References
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences ... Company specializing in the development of cannabinoid-based drugs, ... a company overview at three upcoming scientific and ... Annual LD Micro Invitational: ... Date:                     ...
(Date:5/26/2017)... 2017  In response to the opioid epidemic in ... is working with Pfizer to make up to 1 ... to community health centers, free and charitable clinics, public ... "Pfizer has a long-standing commitment to improving health ... safety through educational activities," said Caroline Roan , ...
(Date:5/22/2017)... , May 22, 2017  Lilac Corp, ... Gene-Eden-VIR/Novirin, announces the launch of a new ... the results of a clinical study that showed ... treatment with Gene-Eden-VIR/Novirin in individuals suffering from HPV ... note that there are no other treatments that ...
Breaking Medicine Technology:
(Date:6/20/2017)... MA (PRWEB) , ... June 20, 2017 , ... Kenneth ... International AIDS Society (JIAS). , Dr. Mayer, who joined the JIAS Editorial Board ... is the founding Medical Research Director of Fenway Health and Co-Chair of ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... HOUSTON – ... new website and a host of new options for today’s modern senior. Brazos ... maintain the active, independent lifestyle they love while offering them the services to support ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... content solutions for the enterprise, is proud to announce Touchpoints integrations. ... ticketing systems, company websites, and more to provide a seamless customer experience. , ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... in Cincinnati, OH for leading-edge care, whether or not they have a ... Using the BIOLASE WaterLase® iPlus™ laser, she targets bacteria and damaged tissue without ...
(Date:6/20/2017)... ... ... With certifications and experience that puts them at the top of the ... are currently accepting new patients at their practice for these custom clear aligners. These ... is why they offer the latest in modern dental techniques to ensure that all ...
Breaking Medicine News(10 mins):